|
1
|
Hussain S, Fareed S, Ansari S and Khan S:
Marine natural products: A lead for anti-cancer. Indian J Geo Mar
Sci. 41:27–39. 2012.
|
|
2
|
Imperatore C, Aiello A, D'Aniello F,
Senese M and Menna M: Alkaloids from marine invertebrates as
important leads for anticancer drugs discovery and development.
Molecules. 19:20391–20423. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu YH, Zhu YX, Jiao RH, Tan RX, Yao LY and
Hu WW: Method and medium for producing Fumigaclavine C by
Aspergillus fumigatus Fermentation. China patent, CN 103849663 B.
Filed January 10, 2014; issued May 4. 2016.
|
|
4
|
Yao J, Jiao R, Liu C, Zhang Y, Yu W, Lu Y
and Tan R: Assessment of the cytotoxic and apoptotic effects of
chaetominine in a human leukemia cell line. Biomol Ther (Seoul).
24:147–155. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mahata S, Bharti AC, Shukla S, Tyagi A,
Husain SA and Das BC: Berberine modulates AP-1 activity to suppress
HPV transcription and downstream signaling to induce growth arrest
and apoptosis in cervical cancer cells. Mol Cancer. 10:392011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li S, Lei Y, Jia Y, Li N, Wink M and Ma Y:
Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes
P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells.
Phytomedicine. 19:83–87. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kastan MB and Bartek J: Cell-cycle
checkpoints and cancer. Nature. 432:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kerzendorfer C and O'Driscoll M: Human DNA
damage response and repair deficiency syndromes: Linking genomic
instability and cell cycle checkpoint proficiency. DNA Repair
(Amst). 8:1139–1152. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sánchez-Martínez C, Gelbert LM, Lallena MJ
and de Dios A: Cyclin dependent kinase (CDK) inhibitors as
anticancer drugs. Bioorg Med Chem Lett. 25:3420–3435. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Poi MJ, Knobloch TJ, Sears MT, Uhrig LK,
Warner BM, Weghorst CM and Li J: Coordinated expression of
cyclin-dependent kinase-4 and its regulators in human oral tumors.
Anticancer Res. 34:3285–3292. 2014.PubMed/NCBI
|
|
11
|
Jiao RH, Xu S, Liu JY, Ge HM, Ding H, Xu
C, Zhu HL and Tan RX: Chaetominine, a cytotoxic alkaloid produced
by endophytic Chaetomium sp. IFB-E015. Org Lett. 8:5709–5712. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Smith J, Tho LM, Xu N and Gillespie DA:
The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and
cancer. Adv Cancer Res. 108:73–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yam CH, Fung TK and Poon RY: Cyclin A in
cell cycle control and cancer. Cell Mol Life Sci. 59:1317–1326.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Berthet C, Raj K, Saudan P and Beard P:
How adeno-associated virus Rep78 protein arrests cells completely
in S phase. Proc Natl Acad Sci USA. 102:13634–13639. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kshirsagar UA: Recent developments in the
chemistry of quinazolinone alkaloids. Org Biomol Chem.
13:9336–9352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wahl GM and Carr AM: The evolution of
diverse biological responses to DNA damage: Insights from yeast and
p53. Nat Cell Biol. 3:E277–E286. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang J, Ghio AJ, Gao M, Wei K, Rosen GD
and Upadhyay D: Ambient particulate matter induces alveolar
epithelial cell cycle arrest: Role of G1 cyclins. FEBS Lett.
581:5315–5320. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bartek J, Lukas C and Lukas J: Checking on
DNA damage in S phase. Nat Rev Mol Cell Biol. 5:792–804. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zuco V, Benedetti V and Zunino F: ATM- and
ATR-mediated response to DNA damage induced by a novel
camptothecin, ST1968. Cancer Lett. 292:186–196. 2010. View Article : Google Scholar : PubMed/NCBI
|
